(Q39982647)

16 September 2017

title

Effect of the novel antipsychotic drug perospirone on P-glycoprotein function and expression in Caco-2 cells (English)

1 reference

16 September 2017

1 reference

Yan-Gang Zhou

1

1 reference

16 September 2017

Kun-Yan Li

series ordinal

2

1 reference

16 September 2017

Huan-De Li

series ordinal

3

1 reference

16 September 2017

publication date

14 May 2008

1 reference

European Journal of Clinical Pharmacology

16 September 2017

published in

1 reference

16 September 2017

volume

64

1 reference

16 September 2017

issue

7

1 reference

16 September 2017

page(s)

697-703

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-008-0487-5

16 September 2017

exact match

0 references

cites work

In vitro drug-drug interactions with perospirone and concomitantly administered drugs in human liver microsomes

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-008-0487-5

In vitro metabolism of perospirone in rat, monkey and human liver microsomes

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-008-0487-5

Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells.

21 January 2018

1 reference

12 December 2020

Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response

1 reference

12 December 2020

Perospirone is a new generation antipsychotic: evidence from a positron emission tomography study of serotonin 2 and D2 receptor occupancy in the living human brain.

1 reference

12 December 2020

1 reference

12 December 2020

Perospirone (Sumitomo Pharmaceuticals).

1 reference

12 December 2020

Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds--implications for pharmacokinetics of selected substrates

1 reference

12 December 2020

Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists.

1 reference

12 December 2020

Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.

1 reference

12 December 2020

Perospirone, a novel atypical antipsychotic drug, potentiates fluoxetine-induced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex

1 reference

12 December 2020

ABC drug transporter at the blood-brain barrier: effects on drug metabolism and drug response

1 reference

12 December 2020

Comparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis

1 reference

12 December 2020

The importance of drug-transporting P-glycoproteins in toxicology

1 reference

12 December 2020

In vitro P-glycoprotein affinity for atypical and conventional antipsychotics

1 reference

12 December 2020

Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation

1 reference

12 December 2020

Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors

1 reference

12 December 2020

Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney and other tissues

1 reference

12 December 2020

Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders

1 reference

12 December 2020

The role of multidrug transporters in drug availability, metabolism and toxicity

1 reference

12 December 2020

Efficacy of carbamazepine against neuroleptic-induced akathisia in treatment with perospirone: case series

1 reference

12 December 2020

The effect of perospirone on auditory P300 in schizophrenia: a preliminary study

1 reference

12 December 2020

Steady-state pharmacokinetics of a new antipsychotic agent perospirone and its active metabolite, and its relationship with prolactin response

1 reference

12 December 2020

Immunosuppressors and reversion of multidrug-resistance

1 reference

12 December 2020

Anti-psychotic drugs reverse multidrug resistance of tumor cell lines and human AML cells ex-vivo

1 reference

12 December 2020

Perospirone in the treatment of schizophrenia: effect on verbal memory organization

1 reference

12 December 2020

Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases

1 reference

12 December 2020

Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein

1 reference

12 December 2020

Use of antipsychosis and adjunctive medications by an inner urban community psychiatric service

1 reference

12 December 2020

Overcoming multidrug drug resistance in P-glycoprotein/MDR1-overexpressing cell lines by ecteinascidin 743.

1 reference

12 December 2020

Cytotoxicity of mycotoxins evaluated by the MTT-cell culture assay.

1 reference

12 December 2020

P-Glycoprotein, a gatekeeper in the blood-brain barrier

1 reference

12 December 2020

1 reference

12 December 2020

Comparative efficacy of antipsychotics in the treatment of schizophrenia: a critical assessment

1 reference

12 December 2020

Characterization of human cytochrome P450 enzymes involved in the in vitro metabolism of perospirone

1 reference

12 December 2020

Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells

1 reference

12 December 2020

Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells

1 reference

12 December 2020

Importance of P-glycoprotein at blood-tissue barriers

1 reference

12 December 2020

Therapeutic monitoring of new antipsychotic drugs

1 reference

12 December 2020

P-glycoprotein interaction with risperidone and 9-OH-risperidone studied in vitro, in knock-out mice and in drug-drug interaction experiments

1 reference

12 December 2020

10.1007/S00228-008-0487-5

Identifiers

DOI

1 reference

16 September 2017

1 reference